• Managing the financial aspects of sponsor–payer–clinical site relationships • Case study and implications: investigator payments issues
5 reasons why the right people aren’t joining your trials
May 30th 2024Determining the most effective locations and formats to get your clinical trial in front of willing, eligible participants can seem like a daunting task.. What is the most efficient way to introduce more targeted recruitment approaches?
Mobile Visits in Decentralized Clinical Trials: The Past, Present and Future
May 7th 2024In March 2024, the US FDA issued its guidance, “Artificial Intelligence & Medical Products: How CBER, CDER, CDRH, and OCP are Working Together,” outlining the agency’s objectives for protecting public health as artificial intelligence (AI) and other technologies become more prevalent in healthcare.